Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Fourth Quarter and Year End Results on Thursday, Jun...(sincluding Siemens AG and Intuitive Surg...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Fourth Quarter and Year End Results on Thursday, June 12, 2008
Date:5/13/2008
s, including Siemens AG and Intuitive Surgical, which are the Company's exclusive distribution partners for the sale and servicing of color doppler ultrasound systems and surgical robotic systems respectively. It also arranges financing packages for the supply of medical products to hospitals in China utilizing the export loan and loan guarantee programs of both the U.S. Export-Import Bank and the German KfW Development Bank. With twenty-five years of experience, more than 1,000 employees, and operations in China, Hong Kong, the United States and Germany, the Company's strategy is to expand its cross-cultural reach by providing leading edge healthcare technologies, quality products and services to Greater China's professional communities. Further company information may be found at the Company's websites, http://www.chindex.com and http://www.unitedfamilyhospitals.com .
Statements made in this press release relating to plans, strategies,
objectives, economic performance and trends and other statements that are
not descriptions of historical facts may be forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended
(the "Securities Act"), and Section 21E of the Securities Exchange Act of
1934, as amended (the "Exchange Act"). Forward-looking information is
inherently subject to risks and uncertainties, and actual results could
differ materially from those currently anticipated due to a number of
factors, which include, but are not limited to, the terms, conditions,
covenants, requirements and limitations set forth in the documents relating
to the above financing, risks and uncertainties relating to the development
to completion of the proposed two new and/or expanded hospital facilities
on budget if at all and factors set forth under the heading "Risk Factors"
in our annual report on Form 10-K for the year
'/>"/>
| SOURCE Chindex International, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Third Quarter Results on Friday, February 8, 2008
2. Chindex International, Inc. to Present at 2008 UBS Global Healthcare Services Conference
3. Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement
4. JPMorgans Principal Investment Management Group to Invest in Chindex International, Inc.
5. Newsweek International Editions: Highlights And Exclusives, May 19, 2008
6. International Center for Adult Stem Cell Education Debuts at Spinal Cord Injury Symposium in Greece
7. MINRAD International, Inc. to Discuss 2008 First Quarter Financial Results on Tuesday, May 13, 2008
8. Anacor to Present Clinical and Preclinical Data on Topical Anti-Inflammatory Candidates, AN2728 and AN2898, at the International Investigative Dermatology 2008 Conference
9. Mindray Medical International Announces First Quarter 2008 Results
10. MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
11. MINRAD International, Inc. Announces $40.0 Million Private Placement
Post Your Comments:
Breaking Biology Technology:New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 2New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 3Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease 2MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 2MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 3MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 4Waters Ships First Units of SYNAPT G2 Mass Spectrometer 2
[0] New silicon-germanium nanowires could lead to smaller, more powerful electronic devices[0] Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease[0] MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products[0] Waters Ships First Units of SYNAPT G2 Mass Spectrometer
Other Biology Technology:Albemarle Manufactures Zymes' PTS, the Lead Compound in a Breakthrough Solubilization Technology 2Albemarle Manufactures Zymes' PTS, the Lead Compound in a Breakthrough Solubilization Technology 3Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company 2Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company 3Neogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry 2
Albemarle Manufactures Zymes' PTS, the Lead Compound in a Breakthrough Solubilization TechnologyEncorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical CompanyNeogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry
Breaking Biology News(10 mins):Study reveals H1N1 unexpected weakness 2From fruit fly wings to heart failure -- why Not(ch)? 2Hebrew University, American researchers show 'trigger' to stem cell differentiation 2Experts Urge One Test to Diagnose Diabetes 48085 1Experts Urge One Test to Diagnose Diabetes 48085 2Experts Urge One Test to Diagnose Diabetes 48085 3Express Scripts to Present at William Blair Growth Stock Conference 12491 1Express Scripts to Present at William Blair Growth Stock Conference 12491 2Pharmacyclics to Present at the 8th Annual Needham and Company Life Sciences Conference 12490 1Pharmacyclics to Present at the 8th Annual Needham and Company Life Sciences Conference 12490 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |